<i>FCRL3</i> genetic variants drive autoimmune pathogenesis in multiple sclerosis and neuromyelitis optica spectrum disorders. [PDF]
Huang HF +6 more
europepmc +1 more source
The neuromyelitis optica spectrum disorders [PDF]
openaire +1 more source
Optical coherence tomography angiography biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review. [PDF]
Mirmosayyeb O +6 more
europepmc +1 more source
Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective. [PDF]
Liu L, Guo K, Yang D.
europepmc +1 more source
Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis. [PDF]
Meng H +10 more
europepmc +1 more source
Clinical and immunological differences between primary and autoimmune-associated neuromyelitis optica spectrum disorders: a retrospective study. [PDF]
Tsai HC +7 more
europepmc +1 more source
Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis. [PDF]
Shin W +12 more
europepmc +1 more source
Novel Automated Chemiluminescent Immunoassay for the Detection of Autoantibodies Against Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders. [PDF]
Yamazaki N +3 more
europepmc +1 more source
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders. [PDF]
Yang W, Chen P, Guo J, Feng H, Huang X.
europepmc +1 more source
Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort. [PDF]
Gholizadeh S +14 more
europepmc +1 more source

